# Vorapaxar Study for Maturation of AV Fistulae for Hemodialysis Access

> **NCT02475837** · PHASE2 · COMPLETED · sponsor: **Ken Mahaffey** · enrollment: 17 (actual)

## Conditions studied

- AV Fistula

## Interventions

- **DRUG:** Vorapaxar sulfate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02475837
- **Lead sponsor:** Ken Mahaffey
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-26
- **Primary completion:** 2017-10-23
- **Final completion:** 2017-10-23
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2019-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02475837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02475837, "Vorapaxar Study for Maturation of AV Fistulae for Hemodialysis Access". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02475837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*